Sharechat Logo

Emulex to mop up remaining Endace shares after crossing threshold

Tuesday 2nd April 2013

Text too small?

Emulex Corp, the US computer network provider, will mop up the remaining shares in New Zealand-based, London AIM exchange-listed Endace after crossing the threshold to enforce compulsory acquisition in its fourth extension to the offer.

The New York Stock Exchange-listed Emulex has received 99.9 percent of acceptances as at March 28 for some 76 million British pounds, or US$119.8 million, and has already paid 4.6 million pounds, or US$7.2 million for employee stock options, it said in a statement.

That means it has crossed the 90 percent level needed to enforce compulsory acquisition under New Zealand's Takeovers Code. The remaining 0.1 percent of Endace will cost 102,400 pounds, or US$161,397, Emulex said.

After two extensions, the US company declared the 80.7 million pound offer unconditional in February as slow acceptances initially left it short of meeting provisions to take full ownership. It extended its bid twice more to hit the full takeover target.

The takeover will see Endace de-list from the AIM exchange, where it's struggled to gain investor attention for its innovations in network visibility.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report